Nano-mediated strategy for targeting and treatment of non-small cell lung cancer (NSCLC)

S Ashique, A Garg, N Mishra, N Raina, LC Ming… - Naunyn-Schmiedeberg's …, 2023 - Springer
Lung cancer is the most common type of cancer, with over 2.1 million cases diagnosed
annually worldwide. It has a high incidence and mortality rate, leading to extensive research …

[HTML][HTML] Nano-enabled strategies for the treatment of lung cancer: potential bottlenecks and future perspectives

MK Alshammari, EY Almomen, KF Alshahrani… - Biomedicines, 2023 - mdpi.com
On a global scale, lung cancer is acknowledged to be the major driver of cancer death
attributable to treatment challenges and poor prognosis. Classical cancer treatment …

Recent advances in lung cancer therapy based on nanomaterials: A review

L Gholami, JR Ivari, NK Nasab… - Current Medicinal …, 2023 - ingentaconnect.com
Lung cancer is one of the commonest cancers with a significant mortality rate for both
genders, particularly in men. Lung cancer is recognized as one of the leading causes of …

Nanomedicine as an emerging platform for metastatic lung cancer therapy

D Landesman-Milo, S Ramishetti, D Peer - Cancer and Metastasis …, 2015 - Springer
Metastatic lung cancer is one of the most common cancers leading to mortality worldwide.
Current treatment includes chemo-and pathway-dependent therapy aiming at blocking the …

Nanotechnology-based inhalation treatments for lung cancer: state of the art

J Ahmad, S Akhter, M Rizwanullah, S Amin… - Nanotechnology …, 2015 - Taylor & Francis
Considering the challenges associated with conventional chemotherapy, targeted and local
delivery of chemotherapeutics via nanoparticle (NP) carriers to the lungs is an emerging …

[HTML][HTML] Inhalable formulations to treat non-small cell lung cancer (NSCLC): Recent therapies and developments

C Gupta, A Jaipuria, N Gupta - Pharmaceutics, 2022 - mdpi.com
Cancer has been the leading cause of mortalities, with lung cancer contributing 18% to
overall deaths. Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung …

[HTML][HTML] Smart nanotherapeutics and lung cancer

M Doroudian, MH Azhdari, N Goodarzi, D O'Sullivan… - Pharmaceutics, 2021 - mdpi.com
Lung cancer is a significant health problem worldwide. Unfortunately, current therapeutic
strategies lack a sufficient level of specificity and can harm adjacent healthy cells …

[HTML][HTML] Inhalable nanomedicine for lung cancer treatment

S Zhang, R Li, T Jiang, Y Gao, K Zhong… - Smart Materials in …, 2024 - Elsevier
Lung cancer has surpassed other types of cancer to become the primary cause of cancer-
related deaths. Surgery stands as the foremost clinical treatment strategy available for …

Emerging trends in the novel drug delivery approaches for the treatment of lung cancer

P Sharma, M Mehta, DS Dhanjal, S Kaur… - Chemico-biological …, 2019 - Elsevier
Cancer is one of the major diseases that cause a high number of deaths globally. Of the
major types of cancers, lung cancer is known to be the most chronic form of cancer in the …

[HTML][HTML] Nano targeted therapies made of lipids and polymers have promising strategy for the treatment of lung cancer

ML Essa, MA El-Kemary, EM Ebrahem Saied… - Materials, 2020 - mdpi.com
The introduction of nanoparticles made of polymers, protein, and lipids as drug delivery
systems has led to significant progress in modern medicine. Since the application of …